DYG Versus Cetrorelix in Oocyte Donation

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
Prospective controlled study to assess the reproductive outcomes of OD recipients in which the donors were subjected to the DYG protocol (20mg/day) compared with those subjected to the short protocol with cetrorelix (0.25 mg/day) from Day 7 or since a leading follicle reached 14 mm. The OD cycles were triggered with triptoreline acetate and the trigger criterion was ≥3 follicles of diameter \>18mm.
Epistemonikos ID: a31d3bd9282086042b3ea561f8732bf85df82aa6
First added on: May 14, 2024